Egaceutical Corporation Company
Egaceutical Corp is a research company that demonstrates human age reversal in humans with a triple therapy called EGA®. The triple therapy incorporates knowledge from ten leading theories of aging to allow EGA® to physically control three major pathways in cellular biology resulting in the turning on and keeping on of pattern-recognition and sensing enzymes called sirtuins. Humans have 7 varieties of sirtuins. The three pathways controlled by EGA® include 1) an energy-sensing pathway that senses low energy from NAD+ (as well as NAD+ removal by CD-38) and cAMP; 2) a methylation pathway that also regulates RNA transcription (the turning on of DNA, also called epigenetics); and 3) the reduction/oxidation pathways (REDOX) that are sensed by sulfur-containing thiol groups of proteins. It was established in 2014 in San Diego, California.
Technology:
Geroscience
Industry:
Geroscience
Headquarters:
San Diego, California, United States
Founded Date:
2014-01-01
Investors Number:
1
Total Funding:
$1.3M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership